{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T09:52:22Z","timestamp":1760953942581,"version":"3.44.0"},"reference-count":42,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Reports"],"accepted":{"date-parts":[[2017,5,16]]},"abstract":"<jats:p>A 52-year-old woman with a medical history of cervical and thyroid cancer, hypertension, dyslipidaemia, uncontrolled diabetes and heavy smoking was diagnosed with a new metastatic cholangiocarcinoma. While undergoing palliative chemotherapy, she developed dysarthria and left-sided weakness. Imaging studies showed multiple bilateral ischaemic strokes. On hospital days 2 and 5, she developed worsening neurological symptoms and imaging studies revealed new areas of ischaemia on respective days. Subsequent workup did not revealed a clear aetiology for the multiple ischaemic events and hypercoagulability studies were only significant for a mildly elevated serum D-dimer level. Although guidelines are unclear, full-dose anticoagulation with low molecular weight heparin was initiated given her high risk of stroke recurrence. She was discharged to acute rehabilitation but, within a month, she experienced complications of her malignant disease progression and a new pulmonary thromboembolism. The patient died soon after being discharged home with hospice care.<\/jats:p>","DOI":"10.1136\/bcr-2016-218105","type":"journal-article","created":{"date-parts":[[2017,6,3]],"date-time":"2017-06-03T09:55:12Z","timestamp":1496483712000},"page":"bcr-2016-218105","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Multiple recurrent ischaemic strokes in a patient with cancer: is there a role for the initiation of anticoagulation therapy for secondary stroke prevention?"],"prefix":"10.1136","volume":"2017","clinical-trial-number":[{"clinical-trial-number":"nct01763606","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Giselle Alexandra","family":"Suero-Abreu","sequence":"first","affiliation":[{"name":"Department of Medicine, Rutgers University New Jersey Medical School, Newark, New Jersey, USA"},{"name":"Department of Neurology, Cooper University Hospital, Camden, New Jersey, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia Zhen","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Neurology, Cooper University Hospital, Camden, New Jersey, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryna Karina","family":"Then","sequence":"additional","affiliation":[{"name":"Department of Neurology, Cooper University Hospital, Camden, New Jersey, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2017,6,3]]},"reference":[{"key":"2025082801250732000_2017.jun03_1.bcr-2016-218105.1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000539"},{"key":"2025082801250732000_2017.jun03_1.bcr-2016-218105.2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24325"},{"key":"2025082801250732000_2017.jun03_1.bcr-2016-218105.3","doi-asserted-by":"crossref","first-page":"n\/a","DOI":"10.1002\/ana.22050","article-title":"Coagulopathy and embolic signal in Cancer patients with ischemic stroke","volume":"68","author":"Seok","year":"2010","journal-title":"Ann Neurol"},{"key":"2025082801250732000_2017.jun03_1.bcr-2016-218105.4","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.112.658625"},{"key":"2025082801250732000_2017.jun03_1.bcr-2016-218105.5","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.109.571356"},{"key":"2025082801250732000_2017.jun03_1.bcr-2016-218105.6","first-page":"1039","article-title":"Stroke and Cancer- A complicated relationship","volume":"2","author":"Dearborn","year":"2014","journal-title":"J Neurol Transl Neurosci"},{"key":"2025082801250732000_2017.jun03_1.bcr-2016-218105.7","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.12-5-518"},{"key":"2025082801250732000_2017.jun03_1.bcr-2016-218105.8","doi-asserted-by":"publisher","DOI":"10.3988\/jcn.2011.7.2.53"},{"key":"2025082801250732000_2017.jun03_1.bcr-2016-218105.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2005.03.008"},{"key":"2025082801250732000_2017.jun03_1.bcr-2016-218105.10","article-title":"Cancer-associated thrombotic microangiopathy","volume":"10","author":"Govind Babu","year":"2016","journal-title":"Ecancermedicalscience"},{"key":"2025082801250732000_2017.jun03_1.bcr-2016-218105.11","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20783"},{"key":"2025082801250732000_2017.jun03_1.bcr-2016-218105.12","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-0804"},{"key":"2025082801250732000_2017.jun03_1.bcr-2016-218105.13","doi-asserted-by":"crossref","first-page":"77","DOI":"10.5853\/jos.2016.00570","article-title":"Hypercoagulability and mortality of patients with stroke and active\u00a0cancer: the OASIS-CANCER study","volume":"19","author":"Lee","year":"2017","journal-title":"J Stroke"},{"key":"2025082801250732000_2017.jun03_1.bcr-2016-218105.14","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/ene.13184","article-title":"D-dimer as a predictor of early neurologic deterioration in cryptogenic stroke with active cancer","volume":"24","author":"Nam","year":"2017","journal-title":"Eur J Neurol"},{"key":"2025082801250732000_2017.jun03_1.bcr-2016-218105.15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172793","article-title":"Predictors of 30-day mortality and the risk of recurrent systemic thromboembolism in cancer patients suffering acute ischemic stroke","volume":"12","author":"Nam","year":"2017","journal-title":"PLoS One"},{"key":"2025082801250732000_2017.jun03_1.bcr-2016-218105.16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/502089","article-title":"Comparison of Enoxaparin and Warfarin for Secondary Prevention of Cancer-Associated Stroke","volume":"2015","author":"Jang","year":"2015","journal-title":"J Oncol"},{"key":"2025082801250732000_2017.jun03_1.bcr-2016-218105.17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1447-0594.2011.00796.x"},{"key":"2025082801250732000_2017.jun03_1.bcr-2016-218105.18","doi-asserted-by":"crossref","first-page":"235","DOI":"10.4149\/neo_2011_03_235","article-title":"D-dimer, plasminogen activator inhibitor-1, prothrombin fragments and protein C - role in prothrombotic state of colorectal cancer","volume":"58","author":"Mytnik","year":"2011","journal-title":"Neoplasma"},{"key":"2025082801250732000_2017.jun03_1.bcr-2016-218105.19","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(01)00619-2"},{"key":"2025082801250732000_2017.jun03_1.bcr-2016-218105.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2003.10.003"},{"key":"2025082801250732000_2017.jun03_1.bcr-2016-218105.21","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-10-116327"},{"key":"2025082801250732000_2017.jun03_1.bcr-2016-218105.22","doi-asserted-by":"crossref","unstructured":"Angelini D , Khorana AA . Risk Assessment scores for cancer-associated venous thromboembolic disease. Semin Thromb Hemost 2017.doi:10.1055\/s-0036-1597281","DOI":"10.1055\/s-0036-1597281"},{"key":"2025082801250732000_2017.jun03_1.bcr-2016-218105.23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp030086"},{"key":"2025082801250732000_2017.jun03_1.bcr-2016-218105.24","first-page":"115","article-title":"Cancer-associated thrombosis: focus on extended therapy with dalteparin","volume":"4","author":"Bick","year":"2006","journal-title":"J Support Oncol"},{"key":"2025082801250732000_2017.jun03_1.bcr-2016-218105.25","doi-asserted-by":"publisher","DOI":"10.1007\/s11883-006-0011-2"},{"key":"2025082801250732000_2017.jun03_1.bcr-2016-218105.26","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000129912.56486.2B"},{"key":"2025082801250732000_2017.jun03_1.bcr-2016-218105.27","doi-asserted-by":"publisher","DOI":"10.1159\/000097639"},{"key":"2025082801250732000_2017.jun03_1.bcr-2016-218105.28","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1080\/00313020701230658","article-title":"D-dimer identifies stages in the progression of diabetes mellitus from family history of diabetes to cardiovascular complications","volume":"39","author":"Nwose","year":"2007","journal-title":"Pathology"},{"key":"2025082801250732000_2017.jun03_1.bcr-2016-218105.29","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.thromres.2017.04.018","article-title":"Inverse associations of HDL cholesterol and oxidized HDL with d-dimer in patients with type 2 diabetes mellitus","volume":"155","author":"Ebara","year":"2017","journal-title":"Thromb Res"},{"key":"2025082801250732000_2017.jun03_1.bcr-2016-218105.30","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1055\/s-0037-1614215","article-title":"Evaluation of D-dimer ELISA test in elderly patients with suspected pulmonary embolism","volume":"79","author":"Tardy","year":"1998","journal-title":"Thromb Haemost"},{"key":"2025082801250732000_2017.jun03_1.bcr-2016-218105.31","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(00)00493-9"},{"key":"2025082801250732000_2017.jun03_1.bcr-2016-218105.32","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2013-202122"},{"key":"2025082801250732000_2017.jun03_1.bcr-2016-218105.33","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2015-211521"},{"key":"2025082801250732000_2017.jun03_1.bcr-2016-218105.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2008.01.007"},{"key":"2025082801250732000_2017.jun03_1.bcr-2016-218105.35","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1590\/S0004-282X2012001000019","article-title":"Ischemic stroke in a patient with cholangiocarcinoma: a case study","volume":"70","author":"Chaiyasit","year":"2012","journal-title":"Arq Neuropsiquiatr"},{"key":"2025082801250732000_2017.jun03_1.bcr-2016-218105.36","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.2015.004473"},{"key":"2025082801250732000_2017.jun03_1.bcr-2016-218105.37","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2016-0214"},{"key":"2025082801250732000_2017.jun03_1.bcr-2016-218105.38","doi-asserted-by":"publisher","DOI":"10.1160\/TH12-07-0508"},{"key":"2025082801250732000_2017.jun03_1.bcr-2016-218105.39","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.thromres.2016.10.002","article-title":"Centralizing care of cancer-associated thromboembolism: the Cleveland clinic experience","volume":"147","author":"Rabinovich","year":"2016","journal-title":"Thromb Res"},{"key":"2025082801250732000_2017.jun03_1.bcr-2016-218105.40","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2015-0361"},{"key":"2025082801250732000_2017.jun03_1.bcr-2016-218105.41","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.thromres.2016.07.013","article-title":"Evaluation of US prescription patterns: are treatment guidelines for cancer-associated venous thromboembolism being followed?","volume":"145","author":"Khorana","year":"2016","journal-title":"Thromb Res"},{"key":"2025082801250732000_2017.jun03_1.bcr-2016-218105.42","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.27772"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2016-218105","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T08:25:17Z","timestamp":1756369517000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2016-218105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,3]]},"references-count":42,"alternative-id":["10.1136\/bcr-2016-218105"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2016-218105","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2017,6,3]]}}}